Potentiating effect of imiquimod in the treatment of verrucae vulgares in immunocompromised patients [2]

Acta Dermato-Venereologica

Volumn 80, Issue 4, 2000, Pages 306-307

  Weisshaar, E ^a   Gollnick, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DIPHENCYPRONE; IMIQUIMOD; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; CARBON DIOXIDE LASER; CASE REPORT; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LASER SURGERY; LETTER; MALE; PRIORITY JOURNAL; VERRUCA VULGARIS;

EID: 0033806112     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155500750012261     Document Type: Letter

References (12)

1. Topical immunotherapy of refractory warts
2. Rejection of plantar warts after treatment with diphencyprone
3. Successful treatment of disseminated facial verrucae with contact immunotherapy
4. Verrucae vulgares rejection. A preliminary study on contact dermatitis and cellular immune response
5. Contact immunotherapy of resistant warts with diphenylcyclopropenone
6. Treatment of multiple relapsing warts with diphencyprone
7. Diphencyprone in the management of refractory palmoplantar and periungual warts: An open study
8. Self-administered topical 5% imiquimod cream for external anogenital warts
9. Treatment of genital warts with an immune-response modifier (imiquimod)
10. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod
11. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
12. Cytokine induction by the immunomodulators imiquimod and S-27609